Relación de la coordinación motriz, edad y sexo con la fuerza y agilidad en escolares / Relationship between motor coordination, age and sex with strength and agility in schoolchildren

El objetivo principal fue analizar el efecto de la coordinación motriz, la edad y el sexo sobre la fuerza y agilidad en escolares de 6-11 años. En el estudio participaron 647 escolares de dos centros de educación Primaria (381 niños y 266 niñas). Se ha realizado un análisis de correlación de Pearson para estudiar la relación entre la edad y la coordinación motriz (medida a través del test 3JS) sobre la fuerza (salto horizontal y salto con contramovimiento) y la agilidad (medida a través del test 4x10). Las diferencias relacionadas con el sexo se analizaron a través del test t-Student y la U de Mann-Whitney, dependiendo de si las variables siguen una distribución normal. Se ha aplicado un modelo ANCOVA donde las variables dependientes son el salto horizontal, el salto con contramovimiento y el 4x10, el factor es la variable sexo y las covariables son la coordinación motriz y la edad. Los resultados han mostrado una asociación positiva entre la coordinación motriz y las pruebas utilizadas para valorar la fuerza y la agilidad. La variable sexo tiene una relación significativa con el salto horizontal, salto con contra movimiento y el 4x10. Tras el análisis según modelo ANCOVA realizado en este estudio, la variable sexo influye sobre el salto horizontal y sobre la agilidad, pero no sobre el salto con contramovimiento cuando se elimina el efecto de la coordinación motriz y de la edad de los escolares. (AU)

The aim of this study is to delve into the effect that motor coordination, age and gender have on strength and agility in Primary stage, specifically in students aged 6 to 11 years. 647 schoolchildren from two primary education centers (381 boys and 266 girls) participated in this study. A Pearson correlation analysis has been carried out to study the relationship between age and Motor Coordination (measured through/by the 3JS test) on strength tests (horizontal jump with feet together and jump with counter movement) and agility (measured through/by the 4x10 test). Subsequently, the gender differences in these variables have been studied using the Student's t test or the Mann-Whitney U test, depending on whether the variables follow a normal distribution. Finally, to delve into the objective of the research, an ANCOVA model has been applied where the dependent variables are the horizontal jump, the counter-movement jump and the 4x10, the factor is the gender variable and the covariates are Motor Coordination and age. The results have shown a positive association between the Motor Coordination and the tests used to assess strength and agility. The gender variable has a significant relationship with the horizontal jump, the counter movement jump and the 4x10. After the analysis according to the ANCOVA model carried out in this study, the gender variable influences the horizontal jump and agility, but not the counter-movement jump when the effect of motor coordination and the age of the schoolchildren is eliminated. (AU)

Guselkumab effectiveness, and posology in patients with moderate to severe hidradenitis suppurativa: A retrospective bicentric experience.

Hidradenitis suppurativa (HS) is a chronic, inflammatory, and recalcitrant skin disease of the terminal hair follicle. Therapeutic alternatives in HS are limited nowadays. Adalimumab, is the only approved biological treatment for patients with moderate to severe HS, and some patients do not reach an optimal response, or experience a progressive response loss, needing therapeutic alternatives. IL-23 pathway is also involved in HS pathogenesis, so its blockade could contribute to reach disease control. Guselkumab is a monoclonal antibody targeting the p19 subunit of extracellular IL-23, currently approved for psoriasis in adults, and recently some authors have reported its effectiveness in patients with moderate to severe HS refractory to other systemic treatments, becoming a hope for some patients. However adequate dosing and intervals have not been determined yet, so in most published series, doses approved for psoriasis are commonly used. On this topic a retrospective bicentric study including HS patients treated with guselkumab in the dermatologic departments of university hospitals Puerta de Hierro of Majadahonda (Madrid, Spain) and Doctor Peset of Valencia (Valencia, Spain) was conducted. We reported effectiveness, dosage and frequency of administration in the cohort, in order to establish the most effective dosage regimen and to clarify the potential role of guselkumab for this disease.

Early Tracheostomy for Managing ICU Capacity During the COVID-19 Outbreak: A Propensity-Matched Cohort Study.

BACKGROUND: During the first wave of the COVID-19 pandemic, shortages of ventilators and ICU beds overwhelmed health care systems. Whether early tracheostomy reduces the duration of mechanical ventilation and ICU stay is controversial. RESEARCH QUESTION: Can failure-free day outcomes focused on ICU resources help to decide the optimal timing of tracheostomy in overburdened health care systems during viral epidemics? STUDY DESIGN AND METHODS: This retrospective cohort study included consecutive patients with COVID-19 pneumonia who had undergone tracheostomy in 15 Spanish ICUs during the surge, when ICU occupancy modified clinician criteria to perform tracheostomy in Patients with COVID-19. We compared ventilator-free days at 28 and 60 days and ICU- and hospital bed-free days at 28 and 60 days in propensity score-matched cohorts who underwent tracheostomy at different timings (≤ 7 days, 8-10 days, and 11-14 days after intubation). RESULTS: Of 1,939 patients admitted with COVID-19 pneumonia, 682 (35.2%) underwent tracheostomy, 382 (56%) within 14 days. Earlier tracheostomy was associated with more ventilator-free days at 28 days (≤ 7 days vs > 7 days [116 patients included in the analysis]: median, 9 days [interquartile range (IQR), 0-15 days] vs 3 days [IQR, 0-7 days]; difference between groups, 4.5 days; 95% CI, 2.3-6.7 days; 8-10 days vs > 10 days [222 patients analyzed]: 6 days [IQR, 0-10 days] vs 0 days [IQR, 0-6 days]; difference, 3.1 days; 95% CI, 1.7-4.5 days; 11-14 days vs > 14 days [318 patients analyzed]: 4 days [IQR, 0-9 days] vs 0 days [IQR, 0-2 days]; difference, 3 days; 95% CI, 2.1-3.9 days). Except hospital bed-free days at 28 days, all other end points were better with early tracheostomy. INTERPRETATION: Optimal timing of tracheostomy may improve patient outcomes and may alleviate ICU capacity strain during the COVID-19 pandemic without increasing mortality. Tracheostomy within the first work on a ventilator in particular may improve ICU availability.

The Effects of Biochar on Indigenous Arbuscular Mycorrhizae Fungi from Agroenvironments.

The effects of biochar on soil-plant-microorganisms systems are currently being extensively investigated. Considering that arbuscular mycorrhizal fungi (AMF) play an essential role in nutrient dynamics, the present study aims at understanding vine shoot-derived biochar effects on AMF activity and the impact of their multiplication in soils on water-stress resistance of plants. Three agronomic tests were performed in greenhouse pots. The first experiment evaluated the effects of three factors: final pyrolysis temperature for biochar production (400 °C and 600 °C), application rate (0 weight-wt.- % as a control, 1.5 wt. %, and 3.0 wt. %) and texture of the growing media (sandy-loam and clay-loam origin) on AMF, microbial communities and phosphatase activity. In the second experiment, an indigenous consortium of AMF was multiplied through the solid substrate method and sorghum as a trap plant with biochar addition. This process was compared to a control treatment without biochar. Obtained inocula were tested in a third experiment with lettuce plants under different water irrigation conditions. Results from the first experiment showed a general increase in AMF activity with the addition of the biochar produced at 400 °C in the sandy-loam texture substrate. Results of the second experiment showed that the biochar addition increased AMF root colonization, the number of AMF spores and AMF infective potential. Results of the third experiment showed that biochar-derived AMF inoculum increased AMF root colonization, AMF spores, dry biomass and the SPAD index in a lettuce crop under low-water irrigation conditions.

Pleth variability index may predict preload responsiveness in patients treated with nasal high flow: a physiological study.

The purpose of this study was to determine whether the plethysmographic variability index ("PVi") can predict preload responsiveness in patients with nasal high flow (NHF) (≥30 L/min) with any sign of hypoperfusion. "Preload responsiveness" was defined as a ≥10% increase in stroke volume (SV), measured by transthoracic echocardiography, after passive leg raising. SV and PVi were reassessed in preload responders after receiving a 250-mL fluid challenge. Twenty patients were included and 12 patients (60%) were preload responders. Responders showed higher baseline mean PVi (24% vs. 13%; P = 0.001) and higher mean PVi variation (ΔPVi) after passive leg raising (6.8% vs. -1.7%; P < 0.001). No differences between mean ΔPVi after passive leg raising and mean ΔPVi after fluid challenge were observed (6.8% vs. 7.4%; P = 0.24); and both values were strongly correlated (r = 0.84; P < 0.001). Baseline PVi and ΔPVi after passive leg raising showed excellent diagnostic accuracy identifying preload responders (AUROC 0.92 and 1.00, respectively). Baseline PVi ≥ 16% had a sensitivity of 91.7% and a specificity of 87.5% for detecting preload responders. Similarly, ΔPVi after passive leg raising ≥2% had a 100% of both sensitivity and specificity. Thus, PVi might predict "preload responsiveness" in patients treated with NHF, suggesting that it may guide fluid administration in these patients.NEW & NOTEWORTHY This is the first study that analyzes the use of noninvasive plethysmographic variability index (PVi) for preload assessment in patients treated with nasal high flow (NHF). Its results showed that PVi might identify preload responders. Therefore, PVi may be used in the day-to-day clinical decision-making process in critically ill patients treated with NHF, helping to provide adequate resuscitation volume.